Overview
Advance your metabolic and mitochondrial research with SLU-PP-332 (10 mg). While frequently grouped with peptide-adjacent research compounds, SLU-PP-332 is a synthetic small-molecule agonist targeting estrogen-related receptors (specifically ERRα, alongside ERRβ and ERRγ). Widely characterized in scientific literature as an "exercise mimetic," it is investigated for its capacity to activate transcriptional pathways associated with aerobic endurance, fatty acid oxidation, and mitochondrial biogenesis without mechanical exertion.
Each batch is produced under strict quality standards, vacuum-sealed to preserve structural integrity, and verified via independent laboratory analysis to ensure high purity for cellular and pre-clinical assay applications.
